SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 09/11/2024 at 07:00, 1 year 6 months ago

Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Dupixent achieves significant improvements in disease remission and symptoms in bullous pemphigoid study. Study met primary and key secondary endpoints with beneficial steroid-sparing effect

Dupixent Bullous Pemphigoid Disease Remission Symptoms Steroid-sparing Effect
BRIEF

published on 08/09/2024 at 21:16, 1 year 7 months ago

Sanofi publishes its capital and voting rights figures for July 2024

Share Capital Voting Rights Financial Markets Authority July 2024 Sanofi Actions
PRESS RELEASE

published on 08/09/2024 at 21:11, 1 year 7 months ago

Sanofi: Information concerning the total number of voting rights and shares - July 2024
Sanofi discloses total voting rights and shares as per French Commercial Code and AMF Regulations for July 31, 2024

French Commercial Code Total Voting Rights AMF Regulations Sanofi July 31 2024
BRIEF

published on 08/08/2024 at 07:05, 1 year 7 months ago

Sarclisa Improves Progression-Free Survival for Multiple Myeloma Patients Eligible for Transplant

Clinical Study Sanofi Multiple Myeloma Sarclisa Progression-free Survival
PRESS RELEASE

published on 08/08/2024 at 07:00, 1 year 7 months ago

Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment

Multiple Myeloma Sarclisa Progression-free Survival GMMG-HD7 Study Frontline Treatment
BRIEF

published on 07/22/2024 at 22:10, 1 year 8 months ago

Sanofi Announces Total Number of Voting Rights and Shares for June 2024

Voting Rights French Commercial Code Financial Regulations Sanofi Shares 2024
PRESS RELEASE

published on 07/22/2024 at 22:05, 1 year 8 months ago

Sanofi: Information concerning the total number of voting rights and shares – June 2024
Sanofi discloses total voting rights and shares in accordance with French market regulations. Details available on their website

Voting Rights Investor Relations Regulated Information French Market Sanofi
BRIEF

published on 07/17/2024 at 23:32, 1 year 8 months ago

Results from the XTEND-Kids study show the potential of ALTUVIIIO in severe hemophilia A

Children ALTUVIIO Sanofi-Aventis XTEND-Kids Hemophilia A
PRESS RELEASE

published on 07/17/2024 at 23:27, 1 year 8 months ago

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data showing high-sustained factor levels with once-weekly dosing in children with severe hemophilia A, effective bleed protection, and no inhibitor development to factor VIII

ALTUVIIIO NEJM XTEND-Kids Hemophilia A Factor VIII
BRIEF

published on 06/26/2024 at 23:35, 1 year 9 months ago

Dupixent: Positive Data for Children With Eosinophilic Esophagitis

Clinical Study Children Dupixent Phase III Eosinophilic Esophagitis

Published on 03/26/2026 at 23:00, 7 hours 11 minutes ago

FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 8 hours 6 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 8 hours 11 minutes ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 8 hours 11 minutes ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 9 hours 11 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity

View all ACCESSWIRE

Published on 03/27/2026 at 06:00, 11 minutes ago

Fewer orders and lower sales - US tariffs, currency effects and cost pressure weigh on earnings
Published on 03/27/2026 at 05:15, 56 minutes ago

Neapco Holdings LLC Announces the Official Close of IFA Group Acquisition, Creating a Global Leader in Driveline Solutions
Published on 03/27/2026 at 04:00, 2 hours 11 minutes ago

Tech-Driven Restoration: Saving the World's Critically Endangered White-headed Langur
Published on 03/26/2026 at 20:48, 9 hours 23 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 10 hours 51 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale

View all EQS

Published on 03/26/2026 at 18:17, 11 hours 54 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 12 hours 26 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 21 hours 13 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 22 hours 41 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 1 day 11 hours ago

LNA SANTE : 2025 Annual Results

View all LES ECHOS COMFI WIRE

News